Company / Capital Expenditures
Tanke Biosciences Corp Capital Expenditures History
FY2011-FY2012 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
$856.4K
FY2012
5-year range
$701.0K / $856.4K
FY2011-FY2012
Trend
+22.2%
vs FY2011
Sector context
Sector data unavailable
Latest sector comparison
What the data says
$856,361 in FY2012.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2012, capital expenditures increased 22.2% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2012 | $856.4K | +22.2% |
| FY2011 | $701.0K | - |
As of FY2012 · SEC 10-K · Updated Jun 29, 2026